You are here: Home » Companies » News
Business Standard

Rhizen receives USFDA fast track designation for cancer drug

Fast track designation is awarded to drugs that treat a serious condition and fill an unmet medical need.

Press Trust of India  |  New Delhi 

Pharmaceuticals, drugs, pharma industry, medical, health, lab

Drug firm today said the US health regulator has granted fast track designation to its associate company Rhizen Pharmaceuticals SA's RP6530 (tenalisib), used in treatment of "The US Food and Drug Administration (USFDA) has granted Fast Track Designation for RP6530 (tenalisib)...for the treatment of patients with relapsed/refractory peripheral T- cell lymphoma (PTCL)," said in a filing. Fast track designation is awarded to drugs that treat a serious condition and fill an unmet medical need, it added. of were trading at Rs 522.40 on BSE, up 1.50 per cent from the previous close.

First Published: Mon, December 11 2017. 11:35 IST
RECOMMENDED FOR YOU